Overview

Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Naratriptan Hydrochloride Tablet under fed conditions.
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Naratriptan